Skip to main content

Akanda Corp.

AKAN
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001888014

No open-market purchases or sales by Akanda Corp. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $3.02K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Akanda Corp. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Akanda Corp., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Akanda Corp.
NameTitleLast reported holdingLast filingFilings, past year
HRT Financial LP10% Owner7,816Jan 20, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 20, 2026 (view filing)Jan 155 daysHRT Financial LP10% OwnerPPurchaseClass A Shares+29.0K$1.40+$40.7KNew position15.7K after
Jan 20, 2026 (view filing)Jan 164 daysHRT Financial LP10% OwnerSSaleClass A Shares−7.87K$1.29−$10.1K−50.2%7.82K after